πŸ‡ΊπŸ‡Έ FDA
Patent

US 7906650

Caspase inhibitors and uses thereof

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7906650 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/14, A61P1/16